3 suspended. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Suspended 3 |
Follow Coronavirus Infections: new trials by email Literature Review of Coronavirus Infections trials Research Report on Coronavirus Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19 Experimental vaccine 1, Experimental vaccine 2, Experimental vaccine 3 - COVID-19 | Phase 4 | Suspended | Sinovac Research and Development Co., Ltd. | 480 | 2022-12-20 | 2022-08-11 |
| Coronavirus (COVID-19) ACEi/ARB Investigation Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19 | Phase 4 | Suspended | National University of Ireland, Galway, Ireland | 2414 | 2020-04-30 | 2020-06-30 |
| Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care Hydroxychloroquine, Vitamin C - COVID-19, Corona Virus Infection | Phase 4 | Suspended | Providence Health & Services | 13 | 2020-03-30 | 2020-09-16 |
COVID-19 (3) · Cardiovascular Diseases (1) · Hypertension (1)
Coronaviridae Infections (3) · Infections (3) · Lung Diseases (3) · Nidovirales Infections (3) · Pneumonia (3) · Pneumonia, Viral (3) · RNA Virus Infections (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Virus Diseases (3) · Vascular Diseases (1)
Amlodipine (1) · Angiotensin Receptor Antagonists (1) · Angiotensin-Converting Enzyme Inhibitors (1) · Ascorbic Acid (1) · Bendroflumethiazide (1) · Calcium Channel Blockers (1) · Captopril (1) · Chlorothiazide (1) · Chlorthalidone (1) · Diltiazem (1) · Enalapril (1) · Felodipine (1) · Fosinopril (1) · Hydrochlorothiazide (1) · Hydroxychloroquine (1)
National University of Ireland, Galway, Ireland (1) · Providence Health & Services (1) · Sinovac Research and Development Co., Ltd. (1)
China (1) · Ireland (1) · United States (1)
Brian Kendal, MD (1) · John William McEvoy, MBBCh MHS (1) · Qiuyue Mu, Master (1) · Trista Johnson, PhD, MPH (1)